Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapy.

about

Dexamethasone implant in retinal vein occlusions.

P2860

Q37213278-58092A0C-B5DB-4AD5-8681-8FAC56D89F3A

P2860

Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapy.

Item

http://www.wikidata.org/entity/Q39679791

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Therapeutic effect of dexameth ...... esistant to anti-VEGF therapy.

@en

Therapeutic effect of dexameth ...... esistant to anti-VEGF therapy.

@nl

type

Item

label

Therapeutic effect of dexameth ...... esistant to anti-VEGF therapy.

@en

Therapeutic effect of dexameth ...... esistant to anti-VEGF therapy.

@nl

prefLabel

Therapeutic effect of dexameth ...... esistant to anti-VEGF therapy.

@en

Therapeutic effect of dexameth ...... esistant to anti-VEGF therapy.

@nl

P1476

Therapeutic effect of dexameth ...... esistant to anti-VEGF therapy.

@en

P2093

Behnam Sharareh

http://www.w3.org/2001/XMLSchema#string

Josh Wallsh

http://www.w3.org/2001/XMLSchema#string

Ron Gallemore

http://www.w3.org/2001/XMLSchema#string

P2860

Retinal vein occlusion: pathophysiology and treatment options

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein

Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study

Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study.

Prostaglandin E2 induces interleukin-6 expression in human chondrocytes via cAMP/protein kinase A- and phosphatidylinositol 3-kinase-dependent NF-kappaB activation.

Assessing retinal function with the multifocal technique.

Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.

A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.

Influence of cataract surgery on repeatability and measurements of spectral domain optical coherence tomography.

The influence of cortical, nuclear, subcortical posterior, and mixed cataract on the results of microperimetry.

P304

947-954

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OPTH.S105412

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27307697

http://www.w3.org/2001/XMLSchema#string

P921

dexamethasone

P932

4888726

http://www.w3.org/2001/XMLSchema#string

Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapy.

about

P2860

P2860

Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921

P932